Pain News and Research

Latest Pain News and Research

Coordinated, two-part approach could help reduce hospital-acquired infections

By coordinating with state health departments and communicating with each other about patients with C. difficile and antibiotic-resistant infections, hospitals, long-term acute-care facilities and nursing homes could reduce the number of such hospital-acquired infections (HAIs) by an estimated 619,000 cases in the next five years, a new Centers for Disease Control 9 (CDC)-led report has found.

5 Aug 2015

Access to dental care by low-income Americans becomes exception as only fewer dentists accept Medicaid

More than 2 percent of all emergency department visits are now related to nontraumatic dental conditions, according to a study by researchers at Stanford University, the University of California-San Francisco, Truven Health Analytics and the federal Agency for Healthcare Research and Quality.

5 Aug 2015

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

Halyard Health, Inc. today reported second quarter 2015 results and updated its net sales and adjusted diluted earnings per share outlook for full-year 2015.

4 Aug 2015

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations is pleased to announce the launch of Orthonika, a spinout company from Imperial College London that is developing a novel knee meniscus replacement, MenisciKnit.

4 Aug 2015

People with chronic insomnia may be able to get relief from half of standard sleeping pills

The roughly nine million Americans who rely on prescription sleeping pills to treat chronic insomnia may be able to get relief from as little as half of the drugs, and may even be helped by taking placebos in the treatment plan, according to new research published today in the journal Sleep Medicine by researchers from the Perelman School of Medicine at the University of Pennsylvania.

4 Aug 2015

Special issue of Ergonomics in Design explores health and safety effects of sedentary workplace

Recent research has shown that the more time employees spend in their chairs, the more likely they are to develop serious health problems such as diabetes, heart disease, and obesity. The July special issue of Ergonomics in Design examines the health and safety effects of the sedentary workplace, the pros and cons of alternatives to sitting at work (for example, sit-stand and treadmill workstations, ball chairs), and proposed workplace design solutions.

4 Aug 2015

FAU pre-medical student and surgeon work together on revolutionary procedure alternative to radical mastectomy

Elizabeth Hopkins, an aspiring physician and pre-medical student in the Charles E. Schmidt College of Science at Florida Atlantic University, has spent more than 640 hours shadowing Hilton Becker, M.D., a local plastic and reconstructive surgeon, and an affiliate professor in FAU's Charles E. Schmidt College of Medicine. Together, with Jeffrey Lind II, M.D., they authored a publication in the current issue of Plastic and Reconstructive Surgery Journal, which describes a revolutionary procedure developed by Becker that is an alternative to radical mastectomy.

4 Aug 2015

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the first patient has been enrolled in the Company's pivotal Phase 3 clinical study, study 007, of FV-100 to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

3 Aug 2015

Shionogi’s naldemedine meets primary, secondary endpoints for treatment of opioid-induced constipation

Shionogi today announced that once-daily naldemedine met its primary and secondary endpoints in a phase III study (COMPOSE II) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

3 Aug 2015

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.

3 Aug 2015

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Charleston Laboratories, Inc., an emerging specialty pharmaceutical company, announced initiation of its second clinical development program with a Phase 1 study on its migraine drug candidate, CL-H1T.

3 Aug 2015

Omeros receives EC approval to market Omidria in EU and other European countries

Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.

3 Aug 2015

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

Sorrento Therapeutics, Inc. announced today that it has entered into an exclusive licensing agreement to develop and commercialize multiple prespecified and undisclosed biosimilar or biobetter antibodies from Mabtech Limited, a holding company for premier antibody development and manufacturing companies in China.

3 Aug 2015

2015 Lansinoh Breastfeeding Survey shows many women still struggle to breastfeed their babies

The 2015 Lansinoh Breastfeeding Survey finds nearly all women (96%) agree that breastfeeding is the best way to feed their children, but many still struggle to breastfeed for what they believe to be the ideal amount of time.

3 Aug 2015

Researchers design new driver seat that can be adjusted using simple hand gestures

A multitude of professional drivers suffer from back problems. One cause: driver seats that are inadequately adjusted to each driver's ergonomic needs.

3 Aug 2015

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells.

3 Aug 2015

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

The BRCA gene encodes for the BRCA proteins, BRCA1 and BRCA2. These proteins are very important in repairing DNA, which they do by correcting double-stranded breaks.

2 Aug 2015

New IMA device could improve diagnosis, treatment of chronic musculoskeletal pain

More than 100 million people across Europe suffer from chronic musculoskeletal pain, with an estimated 40 per cent undiagnosed. Ageing populations throughout Europe means that this only going to increase in the coming years.

31 Jul 2015

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.

30 Jul 2015

People with IBD experience higher anxiety risk compared to peers without IBD

People who have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis, have twice the odds of having a generalized anxiety disorder at some point in their lives when compared to peers without IBD, according to a new study published by University of Toronto researchers.

30 Jul 2015

Pain News and Research

Latest Pain News and Research

Coordinated, two-part approach could help reduce hospital-acquired infections

Access to dental care by low-income Americans becomes exception as only fewer dentists accept Medicaid

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

People with chronic insomnia may be able to get relief from half of standard sleeping pills

Special issue of Ergonomics in Design explores health and safety effects of sedentary workplace

FAU pre-medical student and surgeon work together on revolutionary procedure alternative to radical mastectomy

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

Shionogi’s naldemedine meets primary, secondary endpoints for treatment of opioid-induced constipation

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Omeros receives EC approval to market Omidria in EU and other European countries

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

2015 Lansinoh Breastfeeding Survey shows many women still struggle to breastfeed their babies

Researchers design new driver seat that can be adjusted using simple hand gestures

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

New IMA device could improve diagnosis, treatment of chronic musculoskeletal pain

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

People with IBD experience higher anxiety risk compared to peers without IBD

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in